Zydus Lifesciences Limited (ZYDUSLIFE) - Total Assets

Latest as of September 2025: Rs468.97 Billion INR ≈ $5.07 Billion USD

Based on the latest financial reports, Zydus Lifesciences Limited (ZYDUSLIFE) holds total assets worth Rs468.97 Billion INR (≈ $5.07 Billion USD) as of September 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Check cash flow reinvestment rate of Zydus Lifesciences Limited to assess the company's total reinvestment commitment from operating cash flow.

Zydus Lifesciences Limited - Total Assets Trend (2004–2025)

This chart illustrates how Zydus Lifesciences Limited's total assets have evolved over time, based on quarterly financial data. Check Zydus Lifesciences Limited (ZYDUSLIFE) cash flow quality to evaluate the quality of earnings relative to operating cash generation.

Zydus Lifesciences Limited - Asset Composition Analysis

Current Asset Composition (March 2025)

Zydus Lifesciences Limited's total assets of Rs468.97 Billion consist of 45.8% current assets and 54.2% non-current assets.

Asset Category	Amount (INR)	% of Total Assets
Cash & Equivalents	Rs0.00	2.2%
Accounts Receivable	Rs45.85 Billion	12.3%
Inventory	Rs39.44 Billion	10.6%
Property, Plant & Equipment	Rs0.00	0.0%
Intangible Assets	Rs32.24 Billion	8.7%
Goodwill	Rs52.42 Billion	14.1%

Asset Composition Trend (2004–2025)

This chart illustrates how Zydus Lifesciences Limited's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see Zydus Lifesciences Limited market cap and net worth.

Show as percentage

Key Asset Composition Facts

Current vs. Non-Current Assets: Zydus Lifesciences Limited's current assets represent 45.8% of total assets in 2025, an increase from 37.4% in 2004.
Cash Position: Cash and equivalents constituted 2.2% of total assets in 2025, down from 3.3% in 2004.
Tangible vs. Intangible: Intangible assets (including goodwill) make up 22.0% of total assets, an increase from 16.0% in 2004.
Asset Diversification: The largest asset category is goodwill at 14.1% of total assets.

Zydus Lifesciences Limited Competitors by Total Assets

Key competitors of Zydus Lifesciences Limited based on total assets are shown below.

Company	Country	Total Assets
Swedish Orphan Biovitrum AB (publ) ST:SOBI	Sweden	Skr81.26 Billion
Aurobindo Pharma Limited NSE:AUROPHARMA	India	Rs585.02 Billion
Shijiazhuang Yiling Pharmaceutical Co Ltd SHE:002603	China	CN¥14.18 Billion
Shandong Buchang Pharmaceuticals Co Ltd SHG:603858	China	CN¥19.57 Billion
Tianjin Chase Sun Pharmaceutical Co Ltd SHE:300026	China	CN¥10.37 Billion
Zhejiang Hisoar Pharmaceutical Co Ltd SHE:002099	China	CN¥7.28 Billion
Xeris Pharmaceuticals Inc NASDAQ:XERS	USA	$392.01 Million
Procter & Gamble Health Limited NSE:PGHL	India	Rs8.94 Billion

Zydus Lifesciences Limited - Liquidity and Working Capital Analysis

Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.

Key Liquidity Metrics

Metric	Current	1 Year Ago	5 Years Ago
Current Ratio	1.94	2.27	1.09
Quick Ratio	1.44	1.58	0.77
Cash Ratio	0.00	0.00	0.00
Working Capital	Rs88.65 Billion	Rs68.06 Billion	Rs7.84 Billion

Zydus Lifesciences Limited - Advanced Valuation Insights

This section examines the relationship between Zydus Lifesciences Limited's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.

Key Valuation Metrics

Current Price-to-Book Ratio	3.69
Latest Market Cap to Assets Ratio	0.03
Asset Growth Rate (YoY)	27.1%
Total Assets	Rs372.02 Billion
Market Capitalization	$11.74 Billion USD

Valuation Analysis

Below Book Valuation: The market values Zydus Lifesciences Limited's assets below their book value (0.03x), which may indicate investor concerns about asset quality or future growth.

Rapid Asset Growth: Zydus Lifesciences Limited's assets grew by 27.1% over the past year, indicating significant expansion of the company's resource base.

Annual Total Assets for Zydus Lifesciences Limited (2004–2025)

The table below shows the annual total assets of Zydus Lifesciences Limited from 2004 to 2025.

Year	Total Assets	Change
2025-03-31	Rs372.02 Billion ≈ $4.02 Billion	+27.05%
2024-03-31	Rs292.81 Billion ≈ $3.17 Billion	+13.68%
2023-03-31	Rs257.56 Billion ≈ $2.79 Billion	-7.34%
2022-03-31	Rs277.95 Billion ≈ $3.01 Billion	+16.37%
2021-03-31	Rs238.85 Billion ≈ $2.58 Billion	+0.84%
2020-03-31	Rs236.87 Billion ≈ $2.56 Billion	+0.87%
2019-03-31	Rs234.83 Billion ≈ $2.54 Billion	+29.99%
2018-03-31	Rs180.65 Billion ≈ $1.95 Billion	+18.69%
2017-03-31	Rs152.21 Billion ≈ $1.65 Billion	+51.96%
2016-03-31	Rs100.16 Billion ≈ $1.08 Billion	+10.71%
2015-03-31	Rs90.47 Billion ≈ $978.41 Million	+13.28%
2014-03-31	Rs79.86 Billion ≈ $863.71 Million	+8.33%
2013-03-31	Rs73.72 Billion ≈ $797.28 Million	+15.57%
2012-03-31	Rs63.79 Billion ≈ $689.89 Million	+39.67%
2011-03-31	Rs45.67 Billion ≈ $493.93 Million	+22.17%
2010-03-31	Rs37.38 Billion ≈ $404.29 Million	+10.49%
2009-03-31	Rs33.84 Billion ≈ $365.91 Million	+31.66%
2008-03-31	Rs25.70 Billion ≈ $277.92 Million	+27.78%
2007-03-31	Rs20.11 Billion ≈ $217.50 Million	+27.86%
2006-03-31	Rs15.73 Billion ≈ $170.11 Million	+15.64%
2005-03-31	Rs13.60 Billion ≈ $147.10 Million	+1.33%
2004-03-31	Rs13.42 Billion ≈ $145.16 Million	--

About Zydus Lifesciences Limited

NSE:ZYDUSLIFE India Drug Manufacturers - Specialty & Generic

Market Cap

$11.74 Billion

Rs1.09 Trillion INR

Market Cap Rank

#2023 Global

#77 in India

Share Price

Rs1078.70

Change (1 day)

-0.86%

52-Week Range

Rs860.60 - Rs1105.90

All Time High

Rs1302.00